French Society of Cardiology guidelines on exercise tests (part 2): Indications for exercise tests in cardiac diseases.


Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 15 05 2018
accepted: 16 05 2018
pubmed: 11 8 2018
medline: 15 3 2019
entrez: 11 8 2018
Statut: ppublish

Résumé

The exercise test is performed routinely in cardiology; its main indication is the diagnosis of myocardial ischemia, evaluated along with the subject's pretest probability and cardiovascular risk level. Other criteria, such as analysis of repolarization, must be taken into consideration during the interpretation of an exercise test, to improve its predictive value. An exercise test is also indicated for many other cardiac diseases (e.g. rhythm and conduction disorders, severe asymptomatic aortic stenosis, hypertrophic cardiomyopathy, peripheral artery disease, hypertension). Moreover, an exercise test may be indicated for specific populations (women, the elderly, patients with diabetes mellitus, patients in a preoperative context, asymptomatic patients and patients with congenital heart defects). Some cardiac diseases (such as chronic heart failure or arterial pulmonary hypertension) require a cardiopulmonary exercise test. Finally, an exercise test or a cardiopulmonary exercise test is indicated to prescribe a cardiac rehabilitation programme, adapted to the patient.

Identifiants

pubmed: 30093255
pii: S1875-2136(18)30101-3
doi: 10.1016/j.acvd.2018.07.001
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-66

Informations de copyright

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Auteurs

Dany-Michel Marcadet (DM)

Cardiac Rehabilitation Department, Turin Clinic, 75008 Paris, France.

Bruno Pavy (B)

Cardiac Rehabilitation Department, Loire-Vendée-Océan Hospital, boulevard des Régents, BP2, 44270 Machecoul, France. Electronic address: pavy.bruno@wanadoo.fr.

Gilles Bosser (G)

Paediatric and Congenital Cardiology Department, M3C Regional Competences Centre, University Hospital, 54511 Vandoeuvre-les-Nancy, France; EA 3450, Development, Adaptation and Disadvantage, Faculty of Medicine, University of Lorraine, 54600 Villers-lès-Nancy, France.

Frédérique Claudot (F)

Platform for Clinical Research Assistance, University Hospital, 54511 Vandoeuvre-les-Nancy, France; EA 4360 APEMAC, Faculty of Medicine, University of Lorraine, 54600 Villers-lès-Nancy, France.

Sonia Corone (S)

Cardiac Rehabilitation Department, Bligny Medical Centre, 91640 Briis-sous-Forges, France.

Hervé Douard (H)

Cardiac Rehabilitation Department, Bordeaux University Hospital, 33604 Pessac, France.

Marie-Christine Iliou (MC)

Cardiac Rehabilitation Department, Corentin-Celton Hospital, 92130 Issy-Les-Moulineaux, France.

Bénédicte Vergès-Patois (B)

Cardiac Rehabilitation Department, Les Rosiers Clinic, 21000 Dijon, France.

Pascal Amedro (P)

Paediatric and Congenital Cardiology Department, M3C Regional Reference Centre, University Hospital, 34295 Montpellier, France; Physiology and Experimental Biology of Heart and Muscles Laboratory, PHYMEDEXP, UMR CNRS 9214-Inserm U1046, University of Montpellier, 34295 Montpellier, France.

Thierry Le Tourneau (T)

Cardiology Functional Evaluation Department, University Hospital Laennec, 44800 Nantes, France.

Caroline Cueff (C)

Cardiology Functional Evaluation Department, University Hospital Laennec, 44800 Nantes, France.

Taniela Avedian (T)

Cardiac Rehabilitation Department, Turin Clinic, 75008 Paris, France.

Alain Cohen Solal (AC)

Cardiology Department, Hospital Lariboisière, 75010 Paris, France.

François Carré (F)

Department of Sport Medicine, Pontchaillou Hospital, University of Rennes 1, Inserm 1099, 35043 Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH